⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
NVS News
Novartis AG
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Novartis AG - NVS
accessnewswire.com
NVS
Breast Cancer Continues to Impact Communities; New York Rallies Together to Take Action at Susan G. Komen® MORE THAN PINK Walk
businesswire.com
PFE
LLY
NTRA
DGX
GH
NVS
Over Two Million Reached Through the American Cancer Society and NFL's Focus on Increasing Cancer Screening
prnewswire.com
NVS
Global Digital Biomarkers Market Size, Share, Trends, and Forecast, 2026-2036 | AI, Wearables, and Decentralized Trials Drive 13.4% CAGR to USD 34.6 Billion
globenewswire.com
AAPL
GOOGL
ABT
MDLZ
PHG
BIIB
NVS
SNY
ORO Labs Partners with SAP to Deliver Procurement Orchestration as a Solution Extension
prnewswire.com
SAP
KO
PFE
NVS
BMY
GSK
IBM
OMLYCLO® (omalizumab-igec), the first and only FDA-approved interchangeable biosimilar to XOLAIR®, now commercially available in the U.S.
prnewswire.com
NVS
Global Precision Medicine Biotechnology Solutions Market - Strategic Insights and Forecasts, 2026-2031 | AI and Genomics Fuel 11.3% CAGR, Creating a $49.6 Billion Opportunity
globenewswire.com
PFE
NVS
AZN
TMO
BMY
AMGN
ILMN
QGEN
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Novartis AG - NVS
accessnewswire.com
NVS
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Novartis AG - NVS
accessnewswire.com
NVS
American Kidney Fund’s UCKD Summit Helps Drive Early Recognition for Rare and Genetic Kidney Diseases
globenewswire.com
NVS
TVTX
VRTX
ALNY
NTRA
SNY